CoChat

The effects of glucagon and the target of rapamycin (TOR) on skeletal muscle protein synthesis and age-dependent sarcopenia in humans

Adeva-Andany, María M., Fernández-Fernández, Carlos, López-Pereiro, Yosua, Castro-Calvo, Isabel, Carneiro-Freire, Natalia · 2021 · Clinical Nutrition ESPEN
Cited by 19

The DOI matches its Crossref record; 33 of the 33 references it cites were found in a registry or an index.

Abstract

BACKGROUND AND AIMS Human target of rapamycin (TOR) is a kinase that stimulates protein synthesis in the skeletal muscle in response to amino acids and physical activity. METHODS A comprehensive literature search was conducted on the PubMed database from its inception up to May 2021 to retrieve information on the effects of TOR and glucagon on muscle function. Articles written in English regarding human subjects were included. RESULTS l-leucine activates TOR to initiate protein synthesis in the skeletal muscle. Glucagon has a crucial role suppressing skeletal muscle protein synthesis by increasing l-leucine oxidation and the irreversible loss of this amino acid. Glucagon-induced l-leucine oxidation suppresses TOR and attenuates the ability of skeletal muscle to synthesize proteins. Conditions associated with increased glucagon secretion typically feature reduced ability to synthesize proteins in the skeletal muscle that may evolve into sarcopenia. Animal protein ingestion, unlike vegetable protein, stimulates glucagon secretion. High intake of animal protein increases l-leucine oxidation and promotes the use of amino acids as fuel. Sarcopenia and arterial stiffness characteristically occur together in conditions featuring insulin resistance, such as aging. Insulin resistance mediates the relationship between aging and sarcopenia and arterial stiffness. The loss of skeletal muscle fibers that characterizes sarcopenia is followed by collagen and lipid accumulation. Likewise, insulin resistance is associated with arterial stiffness and intima-media thickening due to adaptive accretion of collagen and lipids in the arterial wall. CONCLUSIONS Human TOR participates in the pathogenesis of sarcopenia and arterial stiffness, although its effects remain to be fully elucidated.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.clnesp.2021.06.025

Cites

33 of 33 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 99

  1. Putra, 2021, Protein source and muscle health in older adults: a literature review, Nutrients, 13, 10.3390/nu13030743 · DOI
  2. Deane, 2020, Animal, plant, collagen and blended dietary proteins: effects on musculoskeletal outcomes, Nutrients, 12, 10.3390/nu12092670 · DOI · Paper page
  3. Mirmiran, 2020, A prospective study of dietary meat intake and risk of incident chronic kidney disease, J Ren Nutr, 30, 111
  4. Alvirdizadeh, 2020, A prospective study on total protein, plant protein and animal protein in relation to the risk of incident chronic kidney disease, BMC Nephrol, 21, 489, 10.1186/s12882-020-02079-y · DOI
  5. Yuzbashian, 2015, Associations of dietary macronutrients with glomerular filtration rate and kidney dysfunction: tehran lipid and glucose study, J Nephrol, 28, 173
  6. Rohde, 2001, The TOR kinases link nutrient sensing to cell growth, J Biol Chem, 276, 9583, 10.1074/jbc.R000034200 · DOI · Paper page
  7. Fingar, 2004, Target of rapamycin (TOR): an integrator of nutrient and growth factor signals and coordinator of cell growth and cell cycle progression, Oncogene, 23, 3151, 10.1038/sj.onc.1207542 · DOI · Paper page
  8. Wullschleger, 2005, Molecular organization of target of rapamycin complex 2, J Biol Chem, 280, 30697, 10.1074/jbc.M505553200 · DOI · Paper page
  9. Rosner, 2008, Cytoplasmic and nuclear distribution of the protein complexes mTORC1 and mTORC2: rapamycin triggers dephosphorylation and delocalization of the mTORC2 components rictor and sin1, Hum Mol Genet, 17, 2934, 10.1093/hmg/ddn192 · DOI · Paper page
  10. Song, 2017, Resistance exercise initiates mechanistic target of rapamycin (mTOR) translocation and protein complex co-localisation in human skeletal muscle, Sci Rep, 7, 5028, 10.1038/s41598-017-05483-x · DOI · Paper page
  11. Kotani, 1994, Involvement of phosphoinositide 3-kinase in insulin- or IGF-1-induced membrane ruffling, EMBO J, 13, 2313, 10.1002/j.1460-2075.1994.tb06515.x · DOI · Paper page
  12. Kimball, 1994, Regulation of protein synthesis by insulin, Annu Rev Physiol, 56, 321, 10.1146/annurev.ph.56.030194.001541 · DOI · Paper page
  13. Cenni, 2003, Targeting of the Akt/PKB kinase to the actin skeleton, Cell Mol Life Sci, 60, 2710, 10.1007/s00018-003-3349-4 · DOI
  14. Jacinto, 2004, Mammalian TOR complex 2 controls the actin cytoskeleton and is rapamycin insensitive, Nat Cell Biol, 6, 1122, 10.1038/ncb1183 · DOI · Paper page
  15. Li, 2004, Biochemical and functional characterizations of small GTPase Rheb and TSC2 GAP activity, Mol Cell Biol, 24, 7965, 10.1128/MCB.24.18.7965-7975.2004 · DOI · Paper page
  16. Sarbassov, 2005, Phosphorylation and regulation of Akt/PKB by the rictor-mTOR complex, Science, 307, 1098, 10.1126/science.1106148 · DOI · Paper page
  17. Martin, 2005, The expanding TOR signaling network, Curr Opin Cell Biol, 17, 158, 10.1016/j.ceb.2005.02.008 · DOI · Paper page
  18. Yang, 2006, TSC1/TSC2 and Rheb have different effects on TORC1 and TORC2 activity, Proc Natl Acad Sci U S A, 103, 6811, 10.1073/pnas.0602282103 · DOI · Paper page
  19. Avruch, 2006, Insulin and amino-acid regulation of mTOR signaling and kinase activity through the Rheb GTPase, Oncogene, 25, 6361, 10.1038/sj.onc.1209882 · DOI · Paper page
  20. Wullschleger, 2006, TOR signaling in growth and metabolism, Cell, 124, 471, 10.1016/j.cell.2006.01.016 · DOI · Paper page
  21. Martin, 2007, Rapamycin promotes vascular smooth muscle cell differentiation through insulin receptor substrate-1/phosphatidylinositol 3-kinase/Akt2 feedback signaling, J Biol Chem, 282, 36112, 10.1074/jbc.M703914200 · DOI · Paper page
  22. Liu, 2008, Rapamycin inhibits F-actin reorganization and phosphorylation of focal adhesion proteins, Oncogene, 27, 4998, 10.1038/onc.2008.137 · DOI
  23. Huang, 2008, The TSC1-TSC2 complex is required for proper activation of mTOR complex 2, Mol Cell Biol, 28, 4104, 10.1128/MCB.00289-08 · DOI · Paper page
  24. Sancak, 2008, The Rag GTPases bind raptor and mediate amino acid signaling to mTORC1, Science, 320, 1496, 10.1126/science.1157535 · DOI · Paper page
  25. Takahara, 2013, Evolutionarily conserved regulation of TOR signalling, J Biochem, 154, 1, 10.1093/jb/mvt047 · DOI
  26. Farhan, 2015, Endothelial cell mTOR complex-2 regulates sprouting angiogenesis, PloS One, 10, 10.1371/journal.pone.0135245 · DOI
  27. Walker, 2016, Mechanistic target of rapamycin complex 1 (mTORC1) and mTORC2 as key signaling intermediates in mesenchymal cell activation, J Biol Chem, 291, 6262, 10.1074/jbc.M115.672170 · DOI
  28. Nitulescu, 2018, The Akt pathway in oncology therapy and beyond (Review), Int J Oncol, 53, 2319
  29. Liu, 2002, Amino acids stimulate translation initiation and protein synthesis through an Akt-independent pathway in human skeletal muscle, J Clin Endocrinol Metab, 87, 5553, 10.1210/jc.2002-020424 · DOI · Paper page
  30. Byfield, 2005, hVps34 is a nutrient-regulated lipid kinase required for activation of p70 S6 kinase, J Biol Chem, 280, 33076, 10.1074/jbc.M507201200 · DOI · Paper page
  31. Nobukuni, 2005, Amino acids mediate mTOR/raptor signaling through activation of class 3 phosphatidylinositol 3OH-kinase, Proc Natl Acad Sci U S A, 102, 14238, 10.1073/pnas.0506925102 · DOI · Paper page
  32. Nobukuni, 2007, hvps34, an ancient player, enters a growing game: mTOR Complex1/S6K1 signaling, Curr Opin Cell Biol, 19, 135, 10.1016/j.ceb.2007.02.019 · DOI
  33. Gulati, 2007, Nutrient sensing in the mTOR/S6K1 signalling pathway, Biochem Soc Trans, 35, 236, 10.1042/BST0350236 · DOI · Paper page
  34. Shah, 2000, 4E-BP1 and S6K1: translational integration sites for nutritional and hormonal information in muscle, Am J Physiol Endocrinol Metab, 279, E715, 10.1152/ajpendo.2000.279.4.E715 · DOI · Paper page
  35. Hannan, 2003, Activation of S6K1 (p70 ribosomal protein S6 kinase 1) requires an initial calcium-dependent priming event involving formation of a high-molecular-mass signalling complex, Biochem J, 370, 469, 10.1042/bj20021709 · DOI · Paper page
  36. Vollenbröker, 2009, mTOR regulates expression of slit diaphragm proteins and cytoskeleton structure in podocytes, Am J Physiol Ren Physiol, 296, F418, 10.1152/ajprenal.90319.2008 · DOI · Paper page
  37. Yoon, 2016, Leucyl-tRNA synthetase activates Vps34 in amino acid-sensing mTORC1 signaling, Cell Rep, 16, 1510, 10.1016/j.celrep.2016.07.008 · DOI · Paper page
  38. Sancak, 2010, Ragulator-Rag complex targets mTORC1 to the lysosomal surface and is necessary for its activation by amino acids, Cell, 141, 290, 10.1016/j.cell.2010.02.024 · DOI · Paper page
  39. Korolchuk, 2011, Lysosomal positioning coordinates cellular nutrient responses, Nat Cell Biol, 13, 453, 10.1038/ncb2204 · DOI · Paper page
  40. Gulati, 2008, Amino acids activate mTOR complex 1 via Ca2+/CaM signaling to hVps34, Cell Metabol, 7, 456, 10.1016/j.cmet.2008.03.002 · DOI · Paper page
  41. Castellino, 1987, Effect of insulin and plasma amino acid concentrations on leucine metabolism in man. Role of substrate availability on estimates of whole body protein synthesis, J Clin Invest, 80, 1784, 10.1172/JCI113272 · DOI · Paper page
  42. Fryburg, 1995, Insulin and insulin-like growth factor-I enhance human skeletal muscle protein anabolism during hyperaminoacidemia by different mechanisms, J Clin Invest, 96, 1722, 10.1172/JCI118217 · DOI · Paper page
  43. Volpi, 1996, Contribution of amino acids and insulin to protein anabolism during meal absorption, Diabetes, 45, 1245, 10.2337/diab.45.9.1245 · DOI · Paper page
  44. Wahren, 1976, Effect of protein ingestion on splanchnic and leg metabolism in normal man and in patients with diabetes mellitus, J Clin Invest, 57, 987, 10.1172/JCI108375 · DOI · Paper page
  45. Abumrad, 1982, The effect of leucine infusion on substrate flux across the human forearm, J Surg Res, 32, 453, 10.1016/0022-4804(82)90126-3 · DOI
  46. Pozefsky, 1976, Effects of brief starvation on muscle amino acid metabolism in nonobese man, J Clin Invest, 57, 444, 10.1172/JCI108295 · DOI · Paper page
  47. Gelfand, 1986, Removal of infused amino acids by splanchnic and leg tissues in humans, Am J Physiol, 250, E407
  48. Pozefsky, 1976, Metabolism of forearm tissues in man. Studies with glucagon, Diabetes, 25, 128, 10.2337/diab.25.2.128 · DOI · Paper page
  49. Bennet, 1990, The effect of amino acid infusion on leg protein turnover assessed by L-[15N]phenylalanine and L-[1-13C]leucine exchange, Eur J Clin Invest, 20, 41, 10.1111/j.1365-2362.1990.tb01789.x · DOI · Paper page
  50. Smith, 1992, Flooding with L-[1-13C]leucine stimulates human muscle protein incorporation of continuously infused L-[1-13C]valine, Am J Physiol, 262, E372
  51. Louard, 1995, Overnight branched-chain amino acid infusion causes sustained suppression of muscle proteolysis, Metabolism, 44, 424, 10.1016/0026-0495(95)90047-0 · DOI
  52. Charlton, 1996, Evidence for a catabolic role of glucagon during an amino acid load, J Clin Invest, 98, 90, 10.1172/JCI118782 · DOI · Paper page
  53. Liu, 2001, Branched chain amino acids activate messenger ribonucleic acid translation regulatory proteins in human skeletal muscle, and glucocorticoids blunt this action, J Clin Endocrinol Metab, 86, 2136
  54. Volpi, 1999, Oral amino acids stimulate muscle protein anabolism in the elderly despite higher first-pass splanchnic extraction, Am J Physiol, 277, E513
  55. Dillon, 2009, Amino acid supplementation increases lean body mass, basal muscle protein synthesis, and insulin-like growth factor-I expression in older women, J Clin Endocrinol Metab, 94, 1630, 10.1210/jc.2008-1564 · DOI · Paper page
  56. Volpi, 1998, Exogenous amino acids stimulate net muscle protein synthesis in the elderly, J Clin Invest, 101, 2000, 10.1172/JCI939 · DOI · Paper page
  57. Walker, 2011, Exercise, amino acids, and aging in the control of human muscle protein synthesis, Med Sci Sports Exerc, 43, 2249, 10.1249/MSS.0b013e318223b037 · DOI · Paper page
  58. Vendelbo, 2014, Fasting increases human skeletal muscle net phenylalanine release and this is associated with decreased mTOR signaling, PloS One, 9, 10.1371/journal.pone.0102031 · DOI · Paper page
  59. Bak, 2016, Differential regulation of lipid and protein metabolism in obese vs. lean subjects before and after a 72-h fast, Am J Physiol Endocrinol Metab, 311, E224, 10.1152/ajpendo.00464.2015 · DOI · Paper page
  60. Peng, 2002, The immunosuppressant rapamycin mimics a starvation-like signal distinct from amino acid and glucose deprivation, Mol Cell Biol, 22, 5575, 10.1128/MCB.22.15.5575-5584.2002 · DOI · Paper page
  61. Nair, 1987, Leucine, glucose, and energy metabolism after 3 days of fasting in healthy human subjects, Am J Clin Nutr, 46, 557, 10.1093/ajcn/46.4.557 · DOI
  62. Fryburg, 1990, Effect of starvation on human muscle protein metabolism and its response to insulin, Am J Physiol, 259, E477
  63. Frexes-Steed, 1990, Role of insulin and branched-chain amino acids in regulating protein metabolism during fasting, Am J Physiol, 258, E907
  64. Welle, 1998, High-protein meals do not enhance myofibrillar synthesis after resistance exercise in 62- to 75-yr-old men and women, Am J Physiol, 274, E677
  65. Fiatarone, 1994, Exercise training and nutritional supplementation for physical frailty in very elderly people, N Engl J Med, 330, 1769, 10.1056/NEJM199406233302501 · DOI · Paper page
  66. Mascher, 2007, Changes in signalling pathways regulating protein synthesis in human muscle in the recovery period after endurance exercise, Acta Physiol, 191, 67, 10.1111/j.1748-1716.2007.01712.x · DOI · Paper page
  67. Léger, 2006, Akt signalling through GSK-3beta, mTOR and Foxo1 is involved in human skeletal muscle hypertrophy and atrophy, J Physiol, 576, 923, 10.1113/jphysiol.2006.116715 · DOI · Paper page
  68. Pacy, 1990, Influence of glucagon on protein and leucine metabolism: a study in fasting man with induced insulin resistance, Br J Surg, 77, 791, 10.1002/bjs.1800770723 · DOI
  69. Hartl, 1990, Bradykinin attenuates glucagon-induced leucine oxidation in humans, Am J Physiol, 259, E239
  70. Nair, 1987, Failure of carbohydrate to spare leucine oxidation in obese subjects, Int J Obes, 11, 537
  71. Petrides, 1994, Time-dependent regulation by insulin of leucine metabolism in young healthy adults, Am J Physiol, 267, E361
  72. Klein, 1992, In vivo assessment of the metabolic alterations in glucagonoma syndrome, Metabolism, 41, 1171, 10.1016/0026-0495(92)90005-U · DOI
  73. Zimmerman, 1989, Contribution of insulin resistance to catabolic effect of prednisone on leucine metabolism in humans, Diabetes, 38, 1238, 10.2337/diab.38.10.1238 · DOI
  74. Schwenk, 1987, Effects of leucine, isoleucine, or threonine infusion on leucine metabolism in humans, Am J Physiol, 253, E428
  75. Chiasson, 1975, Gluconeogenesis from alanine in normal postabsorptive man. Intrahepatic stimulatory effect of glucagon, Diabetes, 24, 574, 10.2337/diab.24.6.574 · DOI · Paper page
  76. Boden, 1990, Role of glucagon in disposal of an amino acid load, Am J Physiol, 259, E225
  77. Del Prato, 1983, Effect of insulin replacement on intermediary metabolism in diabetes secondary to pancreatectomy, Diabetologia, 25, 252, 10.1007/BF00279939 · DOI
  78. Vigili de Kreutzenberg, 1990, Glucose turnover and recycling in diabetes secondary to total pancreatectomy: effect of glucagon infusion, J Clin Endocrinol Metab, 70, 1023, 10.1210/jcem-70-4-1023 · DOI
  79. Freund, 1978, Amino acid derangements in patients with sepsis: treatment with branched chain amino acid rich infusions, Ann Surg, 188, 423, 10.1097/00000658-197809000-00017 · DOI · Paper page
  80. Thiessen, 2018, Role of glucagon in protein catabolism, Curr Opin Crit Care, 24, 228
  81. Roth, 1987, Free amino acid levels in muscle and liver of a patient with glucagonoma syndrome, Metabolism, 36, 7, 10.1016/0026-0495(87)90055-2 · DOI
  82. Broyer, 1980, Plasma and muscle free amino acids in children at the early stages of renal failure, Am J Clin Nutr, 33, 1396, 10.1093/ajcn/33.7.1396 · DOI
  83. Canepa, 1992, Nutritional status and muscle amino acids in children with end-stage renal failure, Kidney Int, 41, 1016, 10.1038/ki.1992.154 · DOI
  84. Morgan, 2021, Protein source and quality for skeletal muscle anabolism in young and older adults: a systematic review and meta-analysis, J Nutr, 151, 1901
  85. Miki, 2017, Protein intake, especially vegetable protein intake, is associated with higher skeletal muscle mass in elderly patients with type 2 diabetes, J Diabetes Res, 7985728
  86. Connor, 1978, The plasma lipids, lipoproteins, and diet of the Tarahumara indians of Mexico, Am J Clin Nutr, 31, 1131, 10.1093/ajcn/31.7.1131 · DOI · Paper page
  87. Walrand, 2008, Functional impact of high protein intake on healthy elderly people, Am J Physiol Endocrinol Metab, 295, E921, 10.1152/ajpendo.90536.2008 · DOI · Paper page
  88. Campbell, 1995, Effects of resistance training and dietary protein intake on protein metabolism in older adults, Am J Physiol, 268, E1143
  89. Paddon-Jones, 2008, Role of dietary protein in the sarcopenia of aging, Am J Clin Nutr, 87, 10.1093/ajcn/87.5.1562S · DOI · Paper page
  90. Nieman, 1988, Vegetarian dietary practices and endurance performance, Am J Clin Nutr, 48, 754, 10.1093/ajcn/48.3.754 · DOI
  91. Goodpaster, 2000, Composition of skeletal muscle evaluated with computed tomography, Ann N Y Acad Sci, 904, 18, 10.1111/j.1749-6632.2000.tb06416.x · DOI · Paper page
  92. Sanada, 2010, A cross-sectional study of sarcopenia in Japanese men and women: reference values and association with cardiovascular risk factors, Eur J Appl Physiol, 110, 57, 10.1007/s00421-010-1473-z · DOI · Paper page
  93. Du, 2018, Associations between sarcopenia and metabolic risk factors: a systematic review and meta-analysis, J Obes Metab Syndr, 27, 175, 10.7570/jomes.2018.27.3.175 · DOI · Paper page
  94. Abramowitz, 2018, Muscle mass, BMI, and mortality among adults in the United States: a population-based cohort study, PloS One, 13, 10.1371/journal.pone.0194697 · DOI · Paper page
  95. Solerte, 2008, Nutritional supplements with oral amino acid mixtures increases whole-body lean mass and insulin sensitivity in elderly subjects with sarcopenia, Am J Cardiol, 101, 69E, 10.1016/j.amjcard.2008.03.004 · DOI · Paper page
  96. Solerte, 2008, Improvement of blood glucose control and insulin sensitivity during a long-term (60 weeks) randomized study with amino acid dietary supplements in elderly subjects with type 2 diabetes mellitus, Am J Cardiol, 101
  97. Rasmussen, 2006, Insulin resistance of muscle protein metabolism in aging, Faseb J, 20, 768, 10.1096/fj.05-4607fje · DOI · Paper page
  98. Yoshimura, 2019, Effects of a leucine-enriched amino acid supplement on muscle mass, muscle strength, and physical function in post-stroke patients with sarcopenia: a randomized controlled trial, Nutrition, 58, 1, 10.1016/j.nut.2018.05.028 · DOI · Paper page
  99. Drummond, 2008, Skeletal muscle protein anabolic response to resistance exercise and essential amino acids is delayed with aging, J Appl Physiol, 104, 1452, 10.1152/japplphysiol.00021.2008 · DOI · Paper page

Cited by

See all 19

Metadata

Authors
Adeva-Andany, M. M., Fernández-Fernández, C., López-Pereiro, Y., Castro-Calvo, I., & Carneiro-Freire, N.
Venue
Clinical Nutrition ESPEN
Publisher
Elsevier BV
Published
2021-08
Volume
44
Pages
15-25
ISSN
2405-4577 (ISSN-L)
OpenAlex
W3178735189
Cited by
19
References
33
FWCI
1.05
Type
journal article
Language
en
Open access
closed
Licence
  • www.elsevier.com/tdm/userlicense/1.0/ (tdm)
  • www.elsevier.com/legal/tdmrep-license (tdm)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.